Testing Hypotheses About an Identified Treatment When There are Multiple Endpoints
From MaRDI portal
Recommendations
- Testing Whether an Identified Treatment Is Best
- Improved Tests for Comparing Treatments Against a Control and Other One-Sided Problems
- One-sided tests in clinical trials with multiple endpoints
- Directional multivariate tests rejecting null and negative effects in all variables
- The use of an identity in Anderson for multivariate multiple testing
Cited in
(13)- On O'Brien's OLS and GLS tests for multiple endpoints
- More powerful tests for the sign testing problem
- The emperor's new tests. (With comments and a rejoinder).
- Testing Whether an Identified Treatment Is Best
- On improving the min test for the analysis of combination drug trials
- Improved Tests for Comparing Treatments Against a Control and Other One-Sided Problems
- A Bayesian Group Sequential Approach for Multiple Endpoints
- The use of an identity in Anderson for multivariate multiple testing
- A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials
- An appraisal of some aspects of statistical inference under inequality constraints
- Procedures for testing multiple endpoints in clinical trials: an overview
- One-sided tests in clinical trials with multiple endpoints
- Supplementary test procedures for overall treatment effect
This page was built for publication: Testing Hypotheses About an Identified Treatment When There are Multiple Endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4031063)
